Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties
Authors:
Open Access
- 7 June 1999
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 17 (2) , 115-133
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of Sulphydryl-and Non-Sulphydryl-Containing ACE Inhibitors on Left Ventricular Relaxation in the Isolated Guinea Pig HeartEndothelium, 1997
- Angiotensin-converting enzyme inhibitors: More different than alike?: Focus on cardiac performanceThe American Journal of Cardiology, 1993
- Protection of the Ischemic Myocardium by the Converting-Enzyme Inhibitor ZofenoprilJournal of Cardiovascular Pharmacology, 1992
- Captopril protects against myocardial injury induced by magnesium deficiency.Hypertension, 1991
- Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of actionAmerican Heart Journal, 1991
- BenazeprilCardiovascular Drug Reviews, 1990
- Captopril and enalaprilat do not scavenge the superoxide anionThe American Journal of Cardiology, 1990
- The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pigCardiovascular Drugs and Therapy, 1990
- CilazaprilCardiovascular Drug Reviews, 1990
- Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting EnzymeJournal of Cardiovascular Pharmacology, 1989